Farallon Capital Management LLC Annexon, Inc. Transaction History

Farallon Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $265,237 - $510,362	-125,705 Reduced 49.16%	130,000 $490,000
Q1 2022 May 16, 2022	SELL	$2.73 - $11.94 $551,621 - $2.41 Million	-202,059 Reduced 44.14%	255,705 $698,000
Q4 2021 Feb 14, 2022	SELL	$11.49 - $22.0 $8.04 Million - $15.4 Million	-699,497 Reduced 60.44%	457,764 $5.26 Million
Q3 2021 Nov 15, 2021	SELL	$16.35 - $23.4 $3.28 Million - $4.7 Million	-200,846 Reduced 14.79%	1,157,261 $21.5 Million
Q2 2021 Aug 13, 2021	SELL	$17.81 - $27.48 $1.74 Million - $2.69 Million	-97,739 Reduced 6.71%	1,358,107 $30.6 Million
Q1 2021 May 17, 2021	SELL	$22.0 - $35.01 $2.23 Million - $3.55 Million	-101,415 Reduced 6.51%	1,455,846 $40.5 Million
Q4 2020 Feb 16, 2021	SELL	$20.81 - $30.55 $2.08 Million - $3.06 Million	-100,000 Reduced 6.03%	1,557,261 $39 Million
Q3 2020 Nov 16, 2020	BUY	$17.5 - $30.23 $29 Million - $50.1 Million	1,657,261 New	1,657,261 $40.4 Million

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $249M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.